Bilateral Occipital Infarcts in a Hemodialysis PatientAl-Falki Y.H.
Division of Ophthalmology, King Khalid University, Abha, Kingdom of Saudi Arabia
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Cortical blindness as a complication of hemodialysis is not widely known, though visual disturbances related to uremia have been known for a long time. We recently observed cortical blindness caused by bilateral occipital infarcts in a patient after hemodialysis.
© 2001 S. Karger AG, Basel
Osler W Sir, McCrae T: Modern Medicine. Philadelphia, Lea & Fiebiger, 1914, vol 3, p 910.
Tyler HR, Tyler KL: Neurologic complications; in Eknoyan G, Knochel I (eds): The Systemic Consequences of Renal Failure. Philadelphia, Grune & Stratton, 1986, p 311.
- Servilla KS, Groffel GC: Anterior ischemic optic neuropathy as a complication of hemodialysis. Am J Kidney Dis 1986;8:61.
- Donald I, Moel Y, Kwun A: Cortical blindness as a complication of hemodialysis. J Pediatr 1978;93:890–891.
- Sabah AH: Blindness after cardiac arrest. Postgrad Med J 1968;44:513.
- Hortwitz NH, Wener L: Temporary cortical blindness following angiography. J Neurosurg 1974;40:583.
- Connolly SE, Gordon KB, Horton JC: Salvage of vision after hypotension-induced ischaemic optic neuropathy. Am J Ophthalmol 1994;117:235–242.
Sabeel A, Al-Hazzaa SA, Alfurayh O, Mikkonen P: The dialysed patient who turned blind during a haemodialysis session. Nephrol Dial Transplant 1998;2957–2958.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.